Clinical Trial Update: Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating olanzapine for anorexia nervosa in children and adolescents was terminated. No efficacy or safety results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Eating Disorder | Phase 3 | Status: TERMINATED